Answers are grounded in this paper and cite their sources.
Harnessing nanoscale mechanical cues to direct stem cell fate represents a transformative strategy in cell-engineered tissue regeneration. In this study, we demonstrate that low-frequency ultrasound (LFU) induces nanoscale vertical displacements (30-65 nm) at the cell-substrate interface, effectively promoting osteogenic differentiation of human mesenchymal stem cells (hMSCs). Remarkably, this ultrasound-driven mechanotransduction occurs on both soft and rigid matrices, highlighting the robustness of the approach. Daily 30 min LFU treatments over 7 days result in significant osteogenic commitment, as confirmed by immunofluorescence and gene expression analyses. Mechanistically, the response is mediated by RhoA-ROCK-dependent myosin IIA contractility, with pharmacological inhibition validating the pathway's role in LFU-induced osteogenesis. This noninvasive, scalable, and cost-effective LFU treatment offers an interesting alternative to traditional biochemical or scaffold-based methods, paving the way for ultrasound-based bioreactors in regenerative medicine and 3D bone tissue engineering.
No takes yet. Share an insight, caveat, or question.
Saigaonkar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: